Tizanidine
- Product NDC
- 71610-167
- 11-digit product format
- 716100167
- Labeler code
- 71610
- Product ID
- 71610-167_a03d5407-7fe3-4064-a9cc-bda2f20e1a51
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA076416
- Marketing category
- ANDA
- Marketing start
- 2015-07-28
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71610-167 | TIZANIDINE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Legacy NDC | 20181023_0ad36479-2ff0-40fb-b9cf-6baa35b19184.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71610-167-30 | 71610016730 | 30 TABLET in 1 BOTTLE (71610-167-30) | 30 tablet | 2018-10-08 | 0000-00-00 | No | No | Current |
| 71610-167-53 | 71610016753 | 60 TABLET in 1 BOTTLE (71610-167-53) | 60 tablet | 2018-10-05 | 0000-00-00 | No | No | Current |
| 71610-167-60 | 71610016760 | 90 TABLET in 1 BOTTLE (71610-167-60) | 90 tablet | 2018-10-05 | 0000-00-00 | No | No | Current |